Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Paola A ErbaG Mariani

Abstract

We present here a systematic analysis of lymphoma and MM patients recruited into 2 clinical trials or treated with radretumab according to compassionate use, describing the biodistribution, dosimetry, safety, and clinical activity of radretumab. Uptake in lymphoma lesions, safety, and clinical activity of radretumab radioimmunotherapy (R-RIT) were evaluated in 18 relapsed lymphoma or multiple myeloma patients. In 14 of 18 patients, selective tumor uptake was found; 11 of 15 lymphoma patients, including 9 of 11 with Hodgkin lymphoma (HL), were eligible for R-RIT (a priori criteria-based target-to-bone marrow ratio > 10:1 for EudraCT no. 2005-000545 or > 4:1 for EudraCT no. 2007-007241-12 at dosimetric imaging). Two HL and 1 diffuse large B cell lymphoma patient achieved complete response; 1 HL patient had partial response. Both multiple myeloma patients receiving R-RIT experienced stabilization of disease. Therefore, the overall objective response rate was 40%. Uncomplicated grade 3-4 thrombocytopenia or leukocytopenia was observed in 5 R-RIT patients, lasting 4-129 d. R-RIT showed a favorable benefit and risk profile in advanced relapsed lymphoma patients and induced complete response in 2 heavily pretreated, relapsed HL patien...Continue Reading

References

Sep 28, 2002·International Journal of Cancer. Journal International Du Cancer·Laura BorsiLuciano Zardi
Jun 14, 2005·Expert Opinion on Therapeutic Targets·Andreas Menrad, Hans D Menssen
Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I FisherMorton Coleman
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dietmar BerndorffLudger M Dinkelborg
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Manuela KasparDario Neri
Jul 21, 2006·Leukemia·B G M DurieUNKNOWN International Myeloma Working Group
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Oct 19, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Heather A JaceneRichard L Wahl
Jun 23, 2009·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Andrei IagaruMichael L Goris
Oct 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Angelika Bischof DelaloyeAnton Hagenbeek
Nov 26, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sébastien BaechlerGeorge Sgouros
Mar 15, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marcus CzabankaPeter Vajkoczy

❮ Previous
Next ❯

Citations

May 29, 2013·Pharmacology & Therapeutics·Francesca Pretto, Dario Neri
Mar 19, 2014·Journal of Proteomics·Giuliano EliaDario Neri
Jan 6, 2016·International Journal of Molecular Sciences·Sergey V GudkovAndrei V Zvyagin
Oct 26, 2012·The Journal of Investigative Dermatology·Kathrin SchwagerDario Neri
Nov 18, 2014·Biochemical Society Transactions·Anna-Karin Olsson
Jan 8, 2013·Protein Expression and Purification·Nor Adzimah JohdiMahendra P Deonarain
Aug 6, 2016·Pharmacology & Therapeutics·Rémy Gébleux, Giulio Casi
Mar 15, 2018·Journal of Labelled Compounds & Radiopharmaceuticals·Wen-Ting K Tsai, Anna M Wu
Apr 2, 2019·International Reviews of Immunology·Mahsa EskianNima Rezaei
Apr 15, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Falk SaupeLars Hellman
May 10, 2020·Molecular Oncology·Relinde I Y LieverseLudwig J Dubois
Sep 29, 2020·Frontiers in Immunology·Mohamed A AlfalehAnwar M Hashem
Apr 30, 2014·Cancer Immunology Research·Gian Luca PoliAndrea Bruno
Jan 26, 2021·Journal of Structural Biology·Tiziano OngaroFederico Forneris
Nov 16, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Frederick FasslrinnerMartin Bornhäuser
May 25, 2021·Nuclear Medicine and Biology·Shishu Kant SumanArchana Mukherjee
Mar 5, 2015·Molecular Pharmaceutics·Giulio Casi, Dario Neri
Dec 15, 2018·Molecular Pharmaceutics·Stefan T G BruijnenConny J van der Laken

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.